Antimicrobial peptides, innate immunity, and the normally sterile urinary tract.
about
Ribonuclease 7, an antimicrobial peptide upregulated during infection, contributes to microbial defense of the human urinary tractGenetic Variations in Vesicoureteral Reflux SequelaeOn the role of NMR spectroscopy for characterization of antimicrobial peptidesCathelicidins: family of antimicrobial peptides. A review3D quantitative imaging of unprocessed live tissue reveals epithelial defense against bacterial adhesion and subsequent traversal requires MyD88Evidence for Phenylalanine Zipper-Mediated Dimerization in the X-ray Crystal Structure of a Magainin 2 AnalogueHigh-throughput identification of chemical inhibitors of E. coli Group 2 capsule biogenesis as anti-virulence agentsRibonucleases 6 and 7 have antimicrobial function in the human and murine urinary tract.Waging war against uropathogenic Escherichia coli: winning back the urinary tractHelicobacter pylori downregulates expression of human β-defensin 1 in the gastric mucosa in a type IV secretion-dependent fashion.LL-37 induced cystitis and the receptor for advanced glycation end-products (RAGE) pathway.Vitamin D induction of the human antimicrobial Peptide cathelicidin in the urinary bladder.α-Intercalated cells defend the urinary system from bacterial infectionCandida infections of the genitourinary tract.Human urinary exosomes as innate immune effectors.Human alpha defensin 5 expression in the human kidney and urinary tractToxin-antitoxin systems are important for niche-specific colonization and stress resistance of uropathogenic Escherichia coliThe noncalciotropic actions of vitamin D: recent clinical developments.Interplay between bladder microbiota and urinary antimicrobial peptides: mechanisms for human urinary tract infection risk and symptom severity.Expression and antimicrobial function of beta-defensin 1 in the lower urinary tractA metaproteomics approach to elucidate host and pathogen protein expression during catheter-associated urinary tract infections (CAUTIs).Vitamin D metabolism and innate immunityRole of Hypoxia Inducible Factor-1α (HIF-1α) in Innate Defense against Uropathogenic Escherichia coli Infection.Phenotypic Heterogeneity in Expression of the K1 Polysaccharide Capsule of Uropathogenic Escherichia coli and Downregulation of the Capsule Genes during Growth in UrineExpression and Significance of the HIP/PAP and RegIIIγ Antimicrobial Peptides during Mammalian Urinary Tract InfectionAntimicrobial activity of new green-functionalized oxazoline-based oligomers against clinical isolates.Vitamin D deficiency is an independent risk factor for urinary tract infections after renal transplantsEfficacy of OH-CATH30 and its analogs against drug-resistant bacteria in vitro and in mouse models.A Prospective, Observational Pilot Study of the Use of Urinary Antimicrobial Peptides in Diagnosing Emergency Department Patients With Positive Urine CulturesGenome-wide mapping of cystitis due to Streptococcus agalactiae and Escherichia coli in mice identifies a unique bladder transcriptome that signifies pathogen-specific antimicrobial defense against urinary tract infection.Oral Mucosal Lamina Propria-Progenitor Cells Exert Antibacterial Properties via the Secretion of Osteoprotegerin and Haptoglobin.Integrating "omics" Technologies to Conceptualize Dynamic Antimicrobial Peptide ResponsesThe diagnosis, evaluation and treatment of acute and recurrent pediatric urinary tract infectionsInnate immunity of surfactant proteins A and D in urinary tract infection with uropathogenic Escherichia coliAdenylate cyclase and the cyclic AMP receptor protein modulate stress resistance and virulence capacity of uropathogenic Escherichia coli.Antimicrobial lactoferrin peptides: the hidden players in the protective function of a multifunctional protein.The Cpx stress response system potentiates the fitness and virulence of uropathogenic Escherichia coli.Genomic diversity and fitness of E. coli strains recovered from the intestinal and urinary tracts of women with recurrent urinary tract infectionUrinary tract infections and reduced risk of bladder cancer in Los Angeles.The innate immune response during urinary tract infection and pyelonephritis.
P2860
Q24307881-5A56E4BE-8BB1-4AC9-B164-4BB77D529D04Q26768619-1E406B80-DB6C-476B-8711-6E24AE4A3756Q26830116-677D16C1-0E06-4854-A02B-280D85FB0831Q27027603-ACD52298-59E0-4E57-869B-BE5436C31544Q27322739-10AD139B-0CD8-4E7C-AB65-0A9945105881Q27680196-8A15B598-3C96-4BBB-A740-D6B313450916Q28474866-07D55F08-ACAA-470D-B398-7910A9CB8E4CQ30032297-1F5BD282-1AA8-4DBC-A84F-FCD97969CA38Q33613902-B3EF3FBC-90F8-4FD6-B4C7-4B97579F7325Q33641780-830BFEE6-102F-43CE-A79E-258CED436476Q33690597-B7E0AADC-60FB-4E26-A6B2-2EC9B0A1C15BQ33778591-BA653E33-F153-4175-B379-A05D70A7342DQ33808284-9814F3A3-B472-4BE2-8053-138F0767798FQ33825621-3F03AB55-FA31-4679-A527-36B85C80BE06Q34103485-30CF298C-5289-4071-9AF8-40C1DB9CA174Q34168341-D5B26462-2BD7-4A67-BA4C-8A9A12F9658BQ34440664-E9E15F8B-845E-43E7-A999-8F871AAF2D64Q34532994-F022BF59-5EFF-456F-8913-C36CC26FDB2DQ34655040-45ED567B-29FD-484C-9BC8-0BEA93E86664Q35035519-CD27CB0D-0689-4F7B-8DFB-64F0F6314C86Q35325775-D6EE9C55-D415-406C-B9AA-43144775DD66Q35435053-A553AA7D-AF9D-4DE2-BA67-44C8E92CE06AQ35557736-043317F2-A3DC-41DD-A078-73FDADBCEA8BQ35745575-CAB3D00D-FCE0-4349-9758-0D5D4764D04AQ35866812-9E97530D-DFC0-4143-9DB3-D45A0D2F193CQ35892311-942D55C4-8393-4A49-B3D9-2838E8E28934Q36008953-DDA40F50-21BB-464F-9814-5A1AECBEA26BQ36018591-148837B6-3C73-44CD-B9E4-E8D6EC6EEE52Q36137564-F7648A34-EFC5-4544-8E31-4D92CF35CCBAQ36163174-704C5A83-5E3D-4DC2-B13A-4403164C833CQ36212648-F5BB5F38-F409-481E-89B2-BA8D8CE86916Q36238020-B91146C8-F60F-4C3F-977A-6B7F0356D40CQ36299210-304D26CA-D926-4721-AD69-57A3564DBCCEQ36373248-AFC50042-7652-405F-9914-217D9B568913Q36506067-02A9933C-7203-41EF-9F28-137C4372ECB3Q36716349-EFE2F697-A8FF-4716-A4AD-49ECB80DE38AQ36826891-E993011F-CF1D-4B87-B36B-DBB2AC86A869Q36964199-E585360C-0B72-4C02-99FB-F158E4C74007Q37123550-139BE732-F299-4E33-96D1-B38F38D770E6Q37238866-4B409DE7-A609-4852-AB2F-F0D5F43EC95F
P2860
Antimicrobial peptides, innate immunity, and the normally sterile urinary tract.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Antimicrobial peptides, innate immunity, and the normally sterile urinary tract.
@en
type
label
Antimicrobial peptides, innate immunity, and the normally sterile urinary tract.
@en
prefLabel
Antimicrobial peptides, innate immunity, and the normally sterile urinary tract.
@en
P356
P1476
Antimicrobial peptides, innate immunity, and the normally sterile urinary tract.
@en
P2093
Michael Zasloff
P304
P356
10.1681/ASN.2007050611
P577
2007-10-17T00:00:00Z